Загрузка...
Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
Use of anti-vascular endothelial growth factor (VEGF) therapies was introduced for the treatment of ocular disorders in 2005. In the UK, the current licensed and NICE approved indications are for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), mac...
Сохранить в:
| Опубликовано в: : | Br J Clin Pharmacol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BlackWell Publishing Ltd
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4239964/ https://ncbi.nlm.nih.gov/pubmed/24602183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12371 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|